Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM)
- PMID: 2338944
Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM)
Abstract
The metabolism and cytostatic effects of 3'-azido-3'-deoxythymidine (AZT), one of the most effective agents being used in the treatment of acquired immunodeficiency syndrome, were investigated in the CCRF-CEM line of human T lymphoid cells. The concentration of drug required to inhibit cell growth by 50% (CD50) was significantly lower when the cells were exposed to AZT for 24 hr (CD50 = 50 microM), as compared with 48 or 96 hr (CD50 = 225 and greater than 300 microM, respectively). AZT at 25 microM blocked the progression of cells in S phase for about 12 hr, but this effect was reversed by 24 hr, despite the continued presence of drug in the medium. At this drug concentration, the level of dTTP decreased to about 75% of the control level by 4 hr but rebounded to 30% above normal by 8 hr of drug exposure. dGTP and dATP pool sizes were unchanged, whereas the dCTP pool increased 5-fold. The time course of these biochemical changes indicated that the onset of S phase arrest was not directly related to the decrease in deoxynucleoside triphosphate pools. CCRF-CEM cells incubated with 25 microM AZT accumulated about 0.9 mM 5'-monophosphate (AZTMP) after 4 hr whereas levels of the 5'-di- and 5'-triphosphates (AZTDP and AZTTP) plateaued at about 2 and 5 microM, respectively. After this period, there was a rapid decrease in AZTMP accumulation, to one third its initial level by 24 hr, whereas AZTDP and AZTTP pools decreased to only about 70%. The loss in AZT nucleotide formation with time of drug exposure was associated with a concomitant accumulation of AZTMP in the medium. Cellular excretion of AZTMP was not associated with any detectable cell lysis or leakage of other cellular metabolites. The ability of CCRF-CEM cells to excrete AZTMP may be an important factor limiting the biochemical and biological effects of the drug.
Similar articles
-
Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.Biochem Pharmacol. 1995 Mar 15;49(6):829-37. doi: 10.1016/0006-2952(94)00453-s. Biochem Pharmacol. 1995. PMID: 7702641
-
2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.Mol Pharmacol. 1990 Aug;38(2):237-43. Mol Pharmacol. 1990. PMID: 2166904
-
Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine).Mol Pharmacol. 1999 Dec;56(6):1354-61. doi: 10.1124/mol.56.6.1354. Mol Pharmacol. 1999. PMID: 10570065
-
Mitochondria as cell targets of AZT (zidovudine).Gen Pharmacol. 1998 Oct;31(4):531-8. doi: 10.1016/s0306-3623(98)00041-x. Gen Pharmacol. 1998. PMID: 9792211 Review.
-
Effects of AZT on cellular iron homeostasis.Biometals. 2004 Aug;17(4):443-50. doi: 10.1023/b:biom.0000029478.18225.a0. Biometals. 2004. PMID: 15259365 Review.
Cited by
-
Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.Cancer Chemother Pharmacol. 1995;35(6):489-95. doi: 10.1007/BF00686833. Cancer Chemother Pharmacol. 1995. PMID: 7882457
-
Structural basis for efficient phosphorylation of 3'-azidothymidine monophosphate by Escherichia coli thymidylate kinase.Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14045-50. doi: 10.1073/pnas.95.24.14045. Proc Natl Acad Sci U S A. 1998. PMID: 9826650 Free PMC article.
-
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.Antimicrob Agents Chemother. 2007 May;51(5):1687-93. doi: 10.1128/AAC.01432-06. Epub 2007 Mar 12. Antimicrob Agents Chemother. 2007. PMID: 17353236 Free PMC article.
-
Effect of AZT on thymidine phosphorylation in cultured H9c2, U-937, and Raji cell lines.Biochem Pharmacol. 2008 Apr 15;75(8):1610-5. doi: 10.1016/j.bcp.2008.01.006. Epub 2008 Jan 20. Biochem Pharmacol. 2008. PMID: 18295188 Free PMC article.
-
Cloning, expression, purification, crystallization and preliminary X-ray crystallographic study of thymidylate kinase (TTHA1607) from Thermus thermophilus HB8.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Feb 1;69(Pt 2):118-21. doi: 10.1107/S1744309112050208. Epub 2013 Jan 30. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013. PMID: 23385749 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources